| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $57.7M | +7.6% |
| Cost of Revenue | $6.0M | +17.4% |
| Gross Profit | $51.8M | +6.5% |
| R&D Expense | $45.0M | -0.3% |
| SG&A Expense | $17.6M | -2.2% |
| Operating Income | -$31.6M | +10.1% |
| Interest Expense | $200K | -5.2% |
| Pre-tax Income | -$31.1M | +11.5% |
| Income Tax | $2.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.7M | -0.1% |
| Short-term Investments | $30.2M | +9.8% |
| Accounts Receivable | $20.6M | +71.7% |
| Current Assets | $69.1M | +18.2% |
| Total Assets | $106.1M | +3.2% |
| Current Liabilities | $59.3M | +27.8% |
| Total Liabilities | $107.3M | +22.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$720K | +95.4% |
| Capital Expenditures | $324K | -78.4% |
| Investing Cash Flow | $970K | +120.7% |
| Financing Cash Flow | -$262K | +91.0% |
| Free Cash Flow | -$1.0M | +93.9% |
| +49.1% |
| Net Income | -$33.6M | +8.8% |
| EPS (Basic) | -$0.86 | +16.5% |
| EPS (Diluted) | -$0.86 | +16.5% |
| Stockholders' Equity |
| -$1.2M |
| -107.9% |